Elsevier and our partners in the scientific and health communities have a
shared interest in encouraging wide access to authoritative, peer-reviewed
scientific, technical and medical (STM) information. Disseminating scholarly
information is fundamental to our contribution to advancing scientific and
medical knowledge, and enabling its use and application.
Elsevier-published research is disseminated globally to an ever-growing range
of users by subscription,
as well as through a variety of initiatives, to provide access for non-subscribers
– including patients, the public, and libraries and institutions in the
developing world.
Subscription-based dissemination
For more than 125 years, subscription journals have been highly effective in
balancing the needs of authors and researchers. With the transition from print
to electronic distribution, Elsevier believes that the subscription model will
continue to be the most effective way of sustaining the peer
review system that ensures the quality and integrity of science and
preserving the scientific record for future generations.
Over the past decade, the transition from print to electronic distribution has
enabled Elsevier to dramatically increase access, improve the productivity of
researchers, and deliver greater value to purchasers while at the same time
moderating prices.
As a result:
Over 75% of researchers globally indicate access to scientific journals has
become easier compared to five years ago, with the majority indicating that
they have “good to excellent” access. For many researchers access to journal
articles is not a significant issue, ranking twelfth on their list of
obstacles to improving productivity, and we estimate over 90% of scientific
and medical researchers globally have access to the STM journals that they
need.
Compared to just six years ago, scientists now read 25% more articles per year
from almost twice as many journals, and they do so using up a smaller
percentage of their time. In fact, science is the only information sector
where the time spent gathering information has actually declined relative to
the time spent analyzing.
The cost per article downloaded on ScienceDirect has declined fivefold since
1999. Over the same period countries have reported a decline in cost per
subscribed title of 20% These reductions have been possible because of
flexible purchasing options, including institutional subscriptions options,
site licenses, national licenses, consortia buying and pay-per-view options,
have helped libraries budget and manage costs.
Access for non-subscribers
Through a variety of initiatives, Elsevier provides access to non-subscribers
including patients, the public and the developing world. Some initiatives have
been cited as “Open Access” approaches, a widely used term that covers a range
of different approaches to electronic publishing, such as article sponsorship,
where authors can sponsor non-subscriber access to articles on ScienceDirect,
or author archiving, where authors can archive their final manuscripts to
their institution’s repository or website. These and other approaches
illustrate how Elsevier continually explores and tests new approaches to meet
the needs of the research communities we serve. As we test these approaches we
look to balance the needs of both authors and researchers and allow for cost
recovery and sustained investment in peer review, quality, global
dissemination, and preservation. We, therefore, implement new initiatives
based on facts and the following considerations:
Where are there gaps in the ability to access information, and how can they be
most efficiently closed?
How can we ensure that new models are sustainable and that the continuity of
the scientific record be preserved?
Could a new model potentially compromise the quality of the research we
publish?
How do you tailor the approach for the communities we serve? Does the approach
support how information is used within a specific discipline?
Elsevier is committed to carefully assessing the new models based on these
considerations, and exploring their potential benefits.